Integrated Nuclear Medicine – Precision Navigation for Prostate Cancer Treatment!

Prostate cancer, one of the most common malignant neoplasms among males, must be familiar. How can prostate cancer be detected early, diagnosed with precision and treated effectively? The answer is given by nuclear medicine — through a combination of diagnostic techniques, the patient is provided with a precise and personalized treatment. What is the integration of nuclear medicine? In short, it is a perfect combination of “diagnostic” and “therapeutic”. In nuclear medicine, we can use specific radiopharmaceuticals (i.e. molecular probes), not only “visible” (visible diagnosis), but also “immediate” (target treatment) and truly accurate management of tumours. How does nuclear medicine treat prostate cancer? The most commonly used technologies at present include 68Ga-PSMAPET/CT and 177 Lu-PSMA target treatment, which are star representatives of the integrated nuclear medicine treatment. 1 Precision diagnosis: 68Ga-PSMAPET/CT helps doctors “lock” the location and extent of cancer cells using a radioactive probe that identifies the PSMA molecules on the surface of prostate cancers with an alienity. Its sensitivity and specificity are extremely high and are particularly relevant for early diagnosis, scalability and post-treatment re-emergence testing. 2 Precision treatment: After diagnosis, with the treatment of 177 Lu-PSMA radionuclides, the radiopharmaceuticals will strike cancer cells as precisely as “missiles” and kill tumours by firing beta rays, causing minor damage to the surrounding health tissue and minor side effects. This treatment applies to patients with advanced or transferred prostate cancer. What are the advantages of integrating nuclear medicine? Early detection of early diagnosis: even very small stoves can be seen as “narrowless” in the form of nuclear medicine. High-precision treatment: Target-oriented treatment can effectively kill cancer cells and reduce the side effects of traditional treatment. Real-time efficacy assessment: The treatment can be followed up with the same technology and dynamically evaluated. What are the patients for whom the integration of nuclear medicine is appropriate? 1. Patients suspected of prostate cancer: Need for a clear diagnosis or a scalability. 2. Patients relapsing after treatment: needs to be assessed for re-emergence or for the disease. 3. Patients of late transit: Need for individualized treatment. Carnation: Early symptoms of prostate cancer are not visible and regular screening is important! Male friends, especially those over the age of 50, who have symptoms such as urination difficulties, urine blood, or a family history of prostate cancer, must take care of the medical examination and, if necessary, consult the doctor as to whether a nuclear medical examination is required. Integrated technology in nuclear medicine is giving new hope to people with prostate cancer and giving us greater confidence in fighting disease. Precision, health care, nuclear medicine. Prostate cancer, prostate cancer, prostate cancer, prostate cancer.